Showing results (111-120 of 161) with videos related to
Sort By:
Pageof 17
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2017
Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damageJinwen Tu, Shihani Stoner, Phillip D Fromm, et al.The American Journal of Pathology|March 19, 2016
Transgenic Disruption of Glucocorticoid Signaling in Osteoblasts Attenuates Joint Inflammation in Collagen Antibody-Induced ArthritisJinwen Tu, Yaqing Zhang, Sarah Kim, et al.American Journal of Respiratory and Critical Care Medicine|January 26, 2013
A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsisPeter Kruger, Michael Bailey, Rinaldo Bellomo, et al.Endocrine Reviews|October 7, 2004
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid responseJeremy W Tomlinson, Elizabeth A Walker, Iwona J Bujalska, et al.Calcified Tissue International|June 23, 2011
Can 11β-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease?Mark S Cooper, Hashir Kriel, Adrian Sayers, et al.Arthritis Research & Therapy|October 20, 2012
Synovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritisRowan Hardy, Maria Juarez, Amy Naylor, et al.Journal of Gastroenterology and Hepatology|November 6, 2019
Coagulation abnormalities, bleeding, thrombosis, and management of patients with acute liver failure in Australia and New ZealandStephen Warrillow, Caleb Fisher, Heath Tibballs, et al.Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 12, 2020
Continuous renal replacement therapy and its impact on hyperammonaemia in acute liver failureStephen Warrillow, Caleb Fisher, Heath Tibballs, et al.Bone|September 7, 2014
Disruption of glucocorticoid signaling in chondrocytes delays metaphyseal fracture healing but does not affect normal cartilage and bone developmentJinwen Tu, Holger Henneicke, Yaqing Zhang, et al.The Journal of Clinical Endocrinology and Metabolism|March 11, 2022
Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal OsteopeniaAfroze Abbas, Marian Schini, Gemma Ainsworth, et al.Pageof 17